Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ-Reference-Cited by-同舟云学术

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ

Published:2004-12-01 Issue:11 Volume:114 Page:1564-1576
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Li Andrew C.,Binder Christoph J.,Gutierrez Alejandra,Brown Kathleen K.,Plotkin Christine R.,Pattison Jennifer W.,Valledor Annabel F.,Davis Roger A.,Willson Timothy M.,Witztum Joseph L.,Palinski Wulf,Glass Christopher K.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference73 articles.

1. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs

2. The PPARs: From Orphan Receptors to Drug Discovery

3. Nuclear Receptors and Lipid Physiology: Opening the X-Files

4. Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis

5. PPAR-RXR Heterodimer Activates a Peroxisome Proliferator Response Element Upstream of the Bifunctional Enzyme Gene

Cited by 409 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-05-31

2. Two peptides LLRLTDL and GYALPCDCL inhibit foam cell formation through activating PPAR‐γ/LXR‐α signaling pathway in oxLDL‐treated RAW264.7 macrophages;BioFactors;2024-05-17

3. PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets;Journal of Advanced Research;2024-03

4. Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection;Frontiers in Cellular and Infection Microbiology;2023-11-29

5. A glimpse of the connection between PPARγ and macrophage;Frontiers in Pharmacology;2023-08-28